Medicinova (MNOV) Financial Statements
Medicinova Financial Overview
Medicinova's market cap is currently $68.91M. The company's EPS TTM is $-0.22; its P/E ratio is -6.45; Medicinova has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 409.66K | $ 0.00 | $ 1.00M | $ 0.00 | $ 4.04M |
| Gross Profit | $ 31.05K | $ 0.00 | $ 1.00M | $ 0.00 | $ 4.04M |
| Operating Income | $ -13.28M | $ -12.68M | $ -9.90M | $ -14.63M | $ -10.22M |
| EBITDA | $ -11.97M | $ -11.02M | $ -8.55M | $ -14.05M | $ -10.11M |
| Net Income | $ -12.00M | $ -11.05M | $ -8.57M | $ -14.07M | $ -10.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 30.81M | $ 40.36M | $ 51.00M | $ 58.49M | $ 71.43M |
| Total Assets | $ 45.60M | $ 55.88M | $ 66.27M | $ 74.15M | $ 87.41M |
| Total Debt | $ 194.33K | $ 193.77K | $ 215.93K | $ 681.12K | $ 826.64K |
| Net Debt | $ -30.61M | $ -40.17M | $ -50.78M | $ -17.82M | $ -70.60M |
| Total Liabilities | $ 4.02M | $ 3.37M | $ 3.89M | $ 3.91M | $ 3.73M |
| Stockholders' Equity | $ 41.59M | $ 52.50M | $ 62.38M | $ 70.24M | $ 83.68M |
| Cash Flow | |||||
| Free Cash Flow | $ -9.81M | $ -10.64M | $ -7.45M | $ -12.92M | $ -9.41M |
| Operating Cash Flow | $ -9.81M | $ -10.64M | $ -7.43M | $ -12.91M | $ -9.38M |
| Investing Cash Flow | $ -2.90K | $ -697.00 | $ 39.91M | $ -40.01M | $ -28.73K |
| Financing Cash Flow | $ 244.02K | $ 0.00 | $ 0.00 | $ 7.92K | $ 20.78M |
Currency in USD